aspecte clinico-diagnostice - Ion Mereuta

Ion Mereuţă, Iraida Iacovlev, Oxana Pihut
12. Ashicari R, Rosen P.P. et al. Breast cancer presenting as axillary mass. In:
Ann. Surg. 1976, nr 9, p. 415-417.
13. Assadi M. A simple way to distinguich bed clothing contamination in a
whole body bone scan: a case report / M. Assadi, A Ebrahimi, M. Eftekhari et al.
In: Journal Med. Case Reports. 2007, vol.1, nr 1, p. 173.
14. Baier M. Application fur tumormarker. In: Mitt.Dtsch.Klin.Chem. 1989, vol.
20, nr 2, p.54-57.
15. Barlogie B., Drewinko B., Schumann J. et al. Cellular DNA content as a
marker of neoplasia in a man. In: Amer. J. Med. 1980, nr 69, p.195-203.
16. Baron P.L., Gandara I. Et al. Bony metastases as the first manifestation of a
tumor. In: Int. Ortop. 1991, vol.15, nr 4, p.373-376.
17. Baron P.L., Moore M.P. et al. Occult breast cancer presenting with axillary
metastasis. In: Arch.Surg. 1990, vol. 125, nr 2, p.210-214.
18. Bates S. E. Clinical applications of serum tumor markers. In: Ann.Int.Med.
1991, vol. 115, nr 8, p.623-638.
19. Bates S. E. The use and potential of serum tumor markers, new and old. In:
Drugs. 1989, vol. 38, nr 1, p.9-18.
20. Bernal M.P., Cazar E.L., Estevez R.A., Uboldi J.R. Tumor primitivo
disconocido. In: Rev. Latinoamer. oncol. clin. 1988, vol. 20, nr 35, p.5-19.
21. Braud F., Sarraf M. Diagnosis and management of squamots cell carcinoma
of unknown primary tumor site of the neck. In: Sem.Oncol. 1993, vol. 20, nr 31,
p.273-278.
22. Bittner H., Rosanowski F., Pottek T. Et al. Metastases of germ cell tumors to
the ENT area – a rare differential diagnosis of lymph node metastases in unknown
primary tumor. In: Laryngorhinootologie. 1996 Oct., nr 75:10, p.616-618.
23. Bordel Gomez M.T., Used Aznar M.M. Cutaneous metastases from
adenocarcinoma of unknown primary site. In: Actas Dermosifiliogr., 2006 Dec, nr
97 (10), р. 662-665.
24. Brown R.W., Campagna L.B., Dunn J.K. et al. Immunohistochemical identification
of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in
the determination of primary site. In: Am.J.Clin. Pathol. 1997 Jan, nr 107:1, p.9-12.
25. Buhmann Kirchhoff S. Detection of osseous metastases of the spine:
Comparison of high resolution multi-detector-CT with MRI. In: Eur. J. Radiol. 2008
Jan, nr 10, p 468-485.
26. Byun W.M. Diffusion-weighted MR imaging of metastatic disease of the
spine: assessment of response to therapy. In: Am. J. Neuroradiol. 2002, vol. 23,
nr. 6, p. 906-912.
27. Cardano S., Cornaglia G., Monteverde A.I. A worrisome scintigraphy. In:
Recenti Prog. Med. 2006 Jul-August, nr 97 (7-8), p. 393-396.
28. Castiato D.A., Chapter 103, Metastasis of unknown origin. In: Haskell,
C.M. (ed). Cancer treatment (4 th ed.)Philadelphia: W.B. Saunders, 1994.
86
Aspecte clinico-diagnostice ale tumorilor maligne secundare cu focare primare necunoscute
29. Castiato D.A., Lowitz B.B. Manual of Clinical Oncology. (Third edition)
Boston- New York-Toronto-London, 1995, p.625.
30. Chee C.P. Brain metastasis of unknown origin. In: Sing.Med.J. 1990, vol.
31, nr 32, p.48-50.
31. Chen YW. et al. Discordant finding of skeletal metastasis between tc 99m
mdp bone scans and f 18 fdg pet/ct imaging for advanced breast and lung cancertwo
case report literature review. In: Kaohsiung Journal Med. Sci. 2007, vol. 23,
nr. 12, p. 639-646.
32. Chevalier T.L., Cvitcovic E., Caille P., Harvey J., Contesso G., Spielmann
M., Rouesse J. Early metastatic cancer of unknown primary origin presentation. A
clinical study of 302 consecutive autopsied patients. In: Arch. Intern. Med. 1988,
vol. 148, p.2035-2039.
33. Cohen A.D., Neuman A., Cohen Y. Serum tumor markers in the diagnosis of
cancer of unknown primary site. In: Harefuah. 1995 Oct., vol. 129:7, nr 8, p.279-282.
34. Corcimaru I. Hemoblastozele. In: Ghid clinic de oncologie. Chişinău 2003.
35. Coşciug G., Donscaia A., Ghidirim N., Suharschi I. Cancerul gastric. In:
Ghid clinic de oncologie. Chişinău 2003, p.
36. Daugaard G. Unknown primary tumours. In: Can.Treat.Rev. 1994, vol. 20,
nr 7, p.119-147.
37. Demirkan B. et al. False negative bone scintigraphy in a patient with primary
breast cancer: a possible transient phenomenon of bisphosphonate (alendronate)
treatment. In: Tumori. 2005, vol. 91, nr 1, p.77-80.
38. De Santo L.W., Neel H.B. Squamous cell carcinoma: metastasis to the neck
from unknown or undiscovered primary. In: Otolaryng.Clin.N.A. 1985, vol. 18,
nr. 3, p.505-513.
39. Destombe C., Botton E., Le Gal G., Roudant A., Jousse Joulin S., Devanchelle-
Pensec V., Saranx A. Investigations for bone metastasis from an unknown primary.
In: Joint Bone Spine. 2007 Jan, nr 74 (1), p.85-89.
40. De Vit R., Hoek F.J., Bakker P.R., Veenho C.H. The value of MCA, CA 15-3,
CEA and CA-125 for discrimination between metastatic breast cancer and
adenocarcinoma of other primary sites. In: J.Int.Med. 1991, vol. 229, nr 5,
p.463-466.
41. Ellerbroek N., Holmes F. Et al. Treatment of patients with isolated axillary
nodal metastases from an occult primary carcinoma consistent with breast origin.
In: Cancer. 1990, vol. 66, nr 7, p.1461-1467.
42. Engelhard K. et al. Comparison of whole-body MRI with automatic moving
table technique and bone scintigraphy for screening for bone metastases in patients
with breast cancer. Eur Radiol. 2004, vol. 14, nr 1, p. 99-105.
43. Erturan S., Yaman M., Aydin G. The role of whole-body bone scanning and
clinical factors in detecting bone metastases in patients with non-small cell lung
cancer. In: Chest. 2005, vol. 127, nr 2, p.449-454.
87